MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 57 filers reported holding MUSTANG BIO INC in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,318,000 | -52.5% | 1,451,409 | -11.2% | 0.00% | -100.0% |
| Q4 2021 | $2,772,000 | -42.6% | 1,633,914 | -2.6% | 0.00% | 0.0% |
| Q3 2021 | $4,831,000 | -19.1% | 1,677,528 | -6.8% | 0.00% | -50.0% |
| Q2 2021 | $5,974,000 | -15.7% | 1,799,480 | -15.7% | 0.00% | 0.0% |
| Q1 2021 | $7,086,000 | +118.0% | 2,134,183 | +148.5% | 0.00% | +100.0% |
| Q4 2020 | $3,251,000 | +608.3% | 858,676 | +488.8% | 0.00% | – |
| Q3 2020 | $459,000 | +97.0% | 145,842 | +99.6% | 0.00% | – |
| Q2 2020 | $233,000 | +5.4% | 73,082 | -11.4% | 0.00% | – |
| Q1 2020 | $221,000 | -35.0% | 82,447 | -1.0% | 0.00% | – |
| Q4 2019 | $340,000 | -37.3% | 83,296 | -49.9% | 0.00% | – |
| Q3 2019 | $542,000 | +19.4% | 166,272 | +34.9% | 0.00% | – |
| Q2 2019 | $454,000 | – | 123,237 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,375,000 | $12,420,000 | 0.88% |
| FNY Investment Advisers, LLC | 200,000 | $736,000 | 0.22% |
| 683 Capital Management, LLC | 625,000 | $2,300,000 | 0.21% |
| HIGHLAND CAPITAL MANAGEMENT LP | 350,000 | $1,288,000 | 0.08% |
| B. Riley Wealth Advisors, Inc. | 107,874 | $397,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 176,400 | $650,000 | 0.02% |
| Quinn Opportunity Partners LLC | 35,514 | $131,000 | 0.02% |
| Frontier Wealth Management LLC | 29,510 | $109,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 15,031 | $55,000 | 0.01% |
| Alyeska Investment Group, L.P. | 165,811 | $610,000 | 0.01% |